Cardiovascular risk in Idiopathic Pulmonary Fibrosis

Emma Denneny and Muhunthan Thillai
Additional contact information
Emma Denneny: University College London, UK
Muhunthan Thillai: Royal Papworth Hospital, UK

International Journal of Pulmonary & Respiratory Sciences, 2018, vol. 3, issue 5, 88-90

Abstract: Idiopathic Pulmonary Fibrosis (IPF) is a progressive interstitial lung disease with a median survival of 3-5 years following diagnosis [1]. Patients most commonly present with cough or dyspnea, and the disease is characterized by a chronic, progressive parenchymal fibrosis with a Usual Interstitial Pneumonia (UIP) histological pattern.

Keywords: uniper publishers:International Journal of Pulmonary; Journal of Pulmonary Sciences; Journal of Pulmonary & Respiratory Sciences; Pulmonary & Respiratory Sciences; pulmonary & respiratory medicine open access journals; pulmonary & respiratory medicine impact factor journals; pulmonary & respiratory medicine peer review journals; chronic obstructive pulmonary disease; pulmonary arterial hypertension impact factor journals; pulmonary aspergillosis high impact factor journals (search for similar items in EconPapers)
Date: 2018
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/ijoprs/pdf/IJOPRS.MS.ID.555623.pdf (application/pdf)
https://juniperpublishers.com/ijoprs/IJOPRS.MS.ID.555623.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:ijoprs:v:3:y:2018:i:5:p:88-90

DOI: 10.19080/IJOPRS.2018.03.555623

Access Statistics for this article

International Journal of Pulmonary & Respiratory Sciences is currently edited by Sophia Mathis

More articles in International Journal of Pulmonary & Respiratory Sciences from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().